Skip to main content

Table 1 Clinical features of colon cancer samples

From: Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

  

Non-responders

Responders

Samples

 

28 (PD)

37

   

7 (CR)

   

19 (PR)

   

11 (SD)

Age, years

 

58.3

57.9

Gender

M

18

24

F

10

13

Localization

R

6

1

L

21

34

 

ND

1

2

Stage at first diagnosis

I

2

0

II

1

5

III

5

2

IV

20

29

ND

0

1

Grade

G1

2

3

G2

24

30

G3

1

1

ND

1

3

Treatment

Cetuximab

23

29

Panitumumab

5

8

OS, average months

 

34.8

61.5

TTP, average months

 

3.6

14.9

  1. PD progressive disease, CR complete response, PR partial response, SD stable disease, M male, F female, R right colon, L left colon, OS overall survival, TTP time to progression, ND not determine
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us